Sundrug Co.,Ltd. (TYO:9989)

Sundrug Revenue

Sundrug had revenue of 215.33B JPY in the quarter ending June 30, 2026, with 3.68% growth. This brings the company's total for the last twelve months to 850.15B, up 4.32% year-over-year. In the fiscal year ending March 31, 2026, Sundrug had annual revenue of 842.51B with 5.08% growth. That makes Sundrug the 2,453rd largest company in the world by revenue and 242nd in Japan.

• Revenue (ttm): 850.15B
• Revenue Growth: +4.32%
• P/S Ratio: 0.50
• Revenue / Employee: 114.01M
• Employees: 7,457
• Market Cap: 427.69B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Drugstore Business 539.38B 59.7%
• Discount Store Business 364.12B 40.3%

Fiscal year ended Mar 31, 2026 See the full Sundrug breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	842.51B	40.70B	5.08%
Mar 31, 2025	801.81B	50.03B	6.66%
Mar 31, 2024	751.78B	61.32B	8.88%
Mar 31, 2023	690.46B	41.73B	6.43%
Mar 31, 2022	648.73B	14.42B	2.27%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error